These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24637708)

  • 21. Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.
    DeZure AD; Berkowitz NM; Graham BS; Ledgerwood JE
    J Infect Dis; 2016 Dec; 214(suppl 5):S497-S499. PubMed ID: 27920180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies.
    Venceslau-Carvalho AA; Teixeira de Pinho Favaro M; Ramos Pereira L; Rodrigues-Jesus MJ; Santos Pereira S; Andreata-Santos R; Dos Santos Alves RP; Castro-Amarante MF; Bitencourt Rodrigues K; Ramos da Silva J; Rahal Guaragna Machado R; Dos Passos Cunha M; Marinho de Andrade Zanotto P; Luzetti Fotoran W; Wunderlich G; Durigon EL; de Souza Ferreira LC
    Nanomedicine; 2021 Oct; 37():102445. PubMed ID: 34303841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial.
    Reisinger EC; Tschismarov R; Beubler E; Wiedermann U; Firbas C; Loebermann M; Pfeiffer A; Muellner M; Tauber E; Ramsauer K
    Lancet; 2019 Dec; 392(10165):2718-2727. PubMed ID: 30409443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cells.
    Verma SK; Gupta N; Pattnaik P; Babu JP; Rao PV; Kumar S
    Protein Pept Lett; 2009; 16(11):1334-41. PubMed ID: 20001924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
    MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Vaccines for Chikungunya Fever.
    Erasmus JH; Rossi SL; Weaver SC
    J Infect Dis; 2016 Dec; 214(suppl 5):S488-S496. PubMed ID: 27920179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of the diagnostic potential of recombinant envelope proteins and native cell culture purified viral antigens of Chikungunya virus.
    Khan M; Dhanwani R; Kumar JS; Rao PV; Parida M
    J Med Virol; 2014 Jul; 86(7):1169-75. PubMed ID: 24105844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.
    García-Arriaza J; Cepeda V; Hallengärd D; Sorzano CÓ; Kümmerer BM; Liljeström P; Esteban M
    J Virol; 2014 Mar; 88(6):3527-47. PubMed ID: 24403588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Western Blot Detection of Human Anti-Chikungunya Virus Antibody with Recombinant Envelope 2 Protein.
    Yang Z; Lee J; Ahn HJ; Chong CK; Dias RF; Nam HW
    Korean J Parasitol; 2016 Apr; 54(2):239-41. PubMed ID: 27180586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates.
    Rossi SL; Comer JE; Wang E; Azar SR; Lawrence WS; Plante JA; Ramsauer K; Schrauf S; Weaver SC
    J Infect Dis; 2019 Jul; 220(5):735-742. PubMed ID: 31053842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Generation and immunogenicity of a recombinant adenovirus expressing the E2 protein of classical swine fever virus in rabbits].
    Sun Y; Qi Q; Liang B; Cheng D; Li N; Yu M; Wang Y; Liu N; Zhu Q; Qiu H
    Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1734-9. PubMed ID: 19149185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological evaluation of Escherichia coli expressed E2 protein of Western equine encephalitis virus.
    Das D; Nagata LP; Suresh MR
    Virus Res; 2007 Sep; 128(1-2):26-33. PubMed ID: 17499379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes containing recombinant E protein vaccine against duck Tembusu virus in ducks.
    Ma T; Liu Y; Cheng J; Liu Y; Fan W; Cheng Z; Niu X; Liu J
    Vaccine; 2016 Apr; 34(19):2157-63. PubMed ID: 27016654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A chikungunya fever vaccine utilizing an insect-specific virus platform.
    Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
    Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein.
    Tripathi NK; Shukla J; Biswal KC; Lakshmana Rao PV
    Appl Microbiol Biotechnol; 2010 May; 86(6):1795-803. PubMed ID: 20177885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective immune response against newly emerging goose tembusu virus infection induced by immunization with a recombinant envelope protein.
    Zhao D; Huang X; Han K; Liu Y; Yang J; Liu Q; An F; Li Y
    Lett Appl Microbiol; 2015 Oct; 61(4):318-24. PubMed ID: 26108865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India.
    Verma A; Nayak K; Chandele A; Singla M; Ratageri VH; Lodha R; Kabra SK; Murali-Krishna K; Ray P
    Arch Virol; 2021 Jul; 166(7):1913-1920. PubMed ID: 33907861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.
    Roques P; Ljungberg K; Kümmerer BM; Gosse L; Dereuddre-Bosquet N; Tchitchek N; Hallengärd D; García-Arriaza J; Meinke A; Esteban M; Merits A; Le Grand R; Liljeström P
    JCI Insight; 2017 Mar; 2(6):e83527. PubMed ID: 28352649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis.
    Kim J; Yang J; Kim YB; Lee HJ; Kim S; Poo H
    Virol Sin; 2019 Oct; 34(5):563-571. PubMed ID: 31214999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody responses induced by recombinant ALV-A gp85 protein vaccine combining with CpG-ODN adjuvant in breeder hens and the protection for their offspring against early infection.
    Zhang D; Li H; Zhang Z; Sun S; Cheng Z; Liu J; Zhao P; Ren Q; Guo H
    Antiviral Res; 2015 Apr; 116():20-6. PubMed ID: 25637708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.